Merck & Co Inc [MRK] stock prices are down -0.36% to $89.19 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The MRK shares have gain 13.53% over the last week, with a monthly amount glided 6.12%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Merck & Co Inc [NYSE: MRK] stock has seen the most recent analyst activity on September 17, 2025, when Berenberg downgraded its rating to a Hold but kept the price target unchanged to $90 for it. Previously, Citigroup downgraded its rating to Neutral on May 14, 2025, and kept the price target unchanged to $84. On April 22, 2025, Cantor Fitzgerald initiated with a Neutral rating and assigned a price target of $85 on the stock. Deutsche Bank downgraded its rating to a Hold and decreased its price target to $105 on February 18, 2025. TD Cowen downgraded its rating to a Hold and reduced its price target to $100 on February 10, 2025. Truist downgraded its rating to Hold for this stock on January 08, 2025, but kept the price target unchanged to $110. In a note dated December 20, 2024, BMO Capital Markets downgraded an Market Perform rating on this stock and revised its target price from $136 to $105.
The stock price of Merck & Co Inc [MRK] has been fluctuating between $73.31 and $112.08 over the past year. Currently, Wall Street analysts expect the stock to reach $90 within the next 12 months. Merck & Co Inc [NYSE: MRK] shares were valued at $89.19 at the most recent close of the market. An investor can expect a potential return of 0.91% based on the average MRK price forecast.
Analyzing the MRK fundamentals
The Merck & Co Inc [NYSE:MRK] reported sales of 63.43B for trailing twelve months, representing a drop of -2.20%. Gross Profit Margin for this corporation currently stands at 0.77% with Operating Profit Margin at 0.31%, Pretax Profit Margin comes in at 0.3%, and Net Profit Margin reading is 0.26%. To continue investigating profitability, this company’s Return on Assets is posted at 0.14, Equity is 0.35 and Total Capital is 0.22. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.72.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 87.96 points at the first support level, and at 86.73 for the second support level. However, for the 1st resistance point, the stock is sitting at 90.56, and for the 2nd resistance point, it is at 91.93.
Ratios To Look Out For
It’s worth pointing out that Merck & Co Inc [NYSE:MRK]’s Current Ratio is 1.42. On the other hand, the Quick Ratio is 1.17, and the Cash Ratio is 0.31. Considering the valuation of this stock, the price to sales ratio is 3.51, the price to book ratio is 4.56 and price to earnings (TTM) ratio is 13.75.
Transactions by insiders
Recent insider trading involved Smart Dalton E. III, SVP Fin. – Global Controller, that happened on Apr 25 ’25 when 4262.0 shares were sold. Officer, DALTON SMART completed a deal on Apr 25 ’25 to buy 4262.0 shares. Meanwhile, President, U.S. Market Oosthuizen Johannes Jacobus sold 8500.0 shares on Feb 19 ’25.
